0001478242-19-000023.txt : 20190327
0001478242-19-000023.hdr.sgml : 20190327
20190327170205
ACCESSION NUMBER: 0001478242-19-000023
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190325
FILED AS OF DATE: 20190327
DATE AS OF CHANGE: 20190327
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BOUSBIB ARI
CENTRAL INDEX KEY: 0001184180
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35907
FILM NUMBER: 19708981
MAIL ADDRESS:
STREET 1: UNITED TECHNOLOGIES CORP
STREET 2: ONE FINANCIAL PLAZA
CITY: HARTFORD
STATE: CT
ZIP: 06101
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IQVIA HOLDINGS INC.
CENTRAL INDEX KEY: 0001478242
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 271341991
STATE OF INCORPORATION: NC
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4820 EMPEROR BLVD.
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: 919-998-2000
MAIL ADDRESS:
STREET 1: 4820 EMPEROR BLVD.
CITY: DURHAM
STATE: NC
ZIP: 27703
FORMER COMPANY:
FORMER CONFORMED NAME: Quintiles IMS Holdings, Inc.
DATE OF NAME CHANGE: 20161003
FORMER COMPANY:
FORMER CONFORMED NAME: Quintiles Transnational Holdings Inc.
DATE OF NAME CHANGE: 20091208
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2019-03-25
0001478242
IQVIA HOLDINGS INC.
IQV
0001184180
BOUSBIB ARI
C/O IQVIA HOLDINGS INC.
83 WOOSTER HEIGHTS ROAD
DANBURY
CT
06810
1
1
0
0
See Remarks
Common Stock
2019-03-25
4
A
0
96000
21.36
A
826137
D
Common Stock
2019-03-25
4
S
0
96000
140.96
D
730137
D
Common Stock
543302
I
By Trust
Employee Stock Option (Right to Buy)
21.36
2019-03-25
4
X
0
96000
0
D
2015-09-01
2020-12-01
Common Stock
96000
0
D
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2018.
The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $139.99 to $141.59 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Shares held in Orohena Trust.
Remarks: Chairman, Chief Executive Officer & President
/s/ Matthew Gilmartin, Attorney-in-Fact for Ari Bousbib
2019-03-27